Related Experiment Videos
Recent advances in skeletal-muscle-based gene therapy
1Department of Medicine, University of Chicago, Illinois 60637, USA.
Current Opinion in Genetics & Development
|August 5, 1998
Summary
Gene transfer into skeletal muscle offers new hope for treating genetic disorders and ischemic conditions. Recent advances in gene therapy vectors, including plasmid DNA, adenovirus, and adeno-associated virus, enable stable and regulated protein expression in muscle tissue.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Gene Therapy
Background:
- Skeletal muscle gene transfer is a promising therapeutic strategy for various genetic and ischemic diseases.
- Recent advancements have focused on developing improved viral and non-viral vectors for efficient gene delivery.
Purpose of the Study:
- To review recent developments in gene transfer vectors for skeletal muscle.
- To highlight novel vectors enabling stable and regulated transgene expression.
Main Methods:
- Review of novel plasmid DNA, adenovirus, and adeno-associated virus vectors.
- Analysis of vector systems for regulated and tissue-specific transgene expression in vivo.
Main Results:
- Development of novel vectors for stable recombinant protein expression in skeletal muscle.
- Creation of vector systems for controlled and tissue-specific gene expression in vivo.
- Demonstration of therapeutic potential for serum protein deficiencies, muscular dystrophies, and ischemic limb syndromes.
Conclusions:
- Novel gene transfer vectors significantly advance the potential for treating skeletal muscle disorders.
- Regulated and tissue-specific gene expression systems enhance the safety and efficacy of muscle gene therapy.